Consun Pharmaceutical Group Ltd. (CPHGF)
1.65
0.00 (0.00%)
USD |
OTCM |
Apr 17, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 1.388B |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 58.10% |
| Valuation | |
| PE Ratio | 9.402 |
| PE Ratio (Forward) | |
| PS Ratio | 2.959 |
| Price to Book Value | -- |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | 0.0511 |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | -- |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 17.50% |
Profile
| Consun Pharmaceutical Group Ltd. is an investment holding company, which engages in the manufacturing and sales of pharmaceutical products. It operates through the Consun Pharmaceutical and Yulin Pharmaceutical segments. The Consun Pharmaceutical segment manufactures and sells modern Chinese medicines and medical contrast medium. The Yulin Pharmaceutical segment retails traditional Chinese medicines. The company was founded by Qian Li in 1997 and is headquartered in Guangzhou, China. |
| URL | http://www.chinaconsun.com |
| Investor Relations URL | N/A |
| HQ State/Province | Guangdong |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | Jun. 10, 2026 |
| Last Ex-Dividend Date | Sep. 05, 2025 |
Profile
| Consun Pharmaceutical Group Ltd. is an investment holding company, which engages in the manufacturing and sales of pharmaceutical products. It operates through the Consun Pharmaceutical and Yulin Pharmaceutical segments. The Consun Pharmaceutical segment manufactures and sells modern Chinese medicines and medical contrast medium. The Yulin Pharmaceutical segment retails traditional Chinese medicines. The company was founded by Qian Li in 1997 and is headquartered in Guangzhou, China. |
| URL | http://www.chinaconsun.com |
| Investor Relations URL | N/A |
| HQ State/Province | Guangdong |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | Jun. 10, 2026 |
| Last Ex-Dividend Date | Sep. 05, 2025 |